ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novartis' Gilenya staves off generic challengers?—for now?—after federal injunction fiercepharma
June 28, 2019Novartis’ multiple sclerosis?med Gilenya is facing U.S. generic challengers on all sides to its blockbuster sales,?and the company hoped a court order could stave them off. The Swiss drugmaker got what it asked for—and it might just keep the med at the to
Pharma Sources Insight January 2025
